Crossmark

A clinical and cost-effectiveness trial of a parent group intervention to manage challenging restricted and repetitive behaviours in young children with autism spectrum disorder: study protocol for a randomised controlled trial

Crossref DOI link: https://doi.org/10.1186/s13063-021-05175-y

Published Online: 2021-04-01

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Grahame, Victoria

Dixon, Linda

Fletcher-Watson, Sue

Garland, Deborah

Glod, Magdalena

Goodwin, Jane

Grayson, Zoe

Heron, Saoirse

Honey, Emma

Iversen, Rebecca

Kasim, Adetayo S.

Kernohan, Ashleigh

Kharatikoopaei, Ehsan

Le Couteur, Ann

Mackie, Leila

Mathias, Ayesha

Probert, Helen

Riby, Deborah

Rob, Priyanka

Rogan, Leanne http://orcid.org/0000-0002-8707-9975
Thompson, Sarah

Vale, Luke

Walls, Eamonn

Webb, Elspeth Imogen

Weetman, Christopher

Wolstenhulme, Faye

Wood, Ruth

Rodgers, Jacqui
Funding

Funding for this research was provided by:

National Institute for Health Research (16/111/95)
License Information

Text and Data Mining valid from 2021-04-01

Version of Record valid from 2021-04-01
More Information

Article History

Received: 15 October 2020

Accepted: 8 March 2021

First Online: 1 April 2021

Declarations

:

: This study received ethical approval from the South West - Cornwall & Plymouth Research Ethics Committee on the 20.08.18 (ref: 18/SW/0173). Informed consent will be obtained from all study participants.

: Not applicable

: Professor Luke Vale was a panel member of the NIHR HTA Clinical Trials and Evaluation Panel until March 2018. There are no other competing interests.

Document is current

Any future updates will be listed below